Cell Culture – News and Features

The Australian Stem Cell Centre, Monash University and the University of California make a major commitment towards stem cell research

The two-year grant will provide Gentronix with two scientists, cell culture facilities, and supporting laboratory instrumentation at its Manchester Incubator Core Technology Facility premises.

Data presented indicates that TPI 287 is orally bioavailable in rats and that oral dosing of TPI 287 has antitumor activity in a mouse xenograft model.

Nanospray mass spectrometry was used to demonstrate the feasibility of detecting norovirus particles in the purified concentrates.

A molecular library created by a research team led by scientists at the Broad Institute of MIT and Harvard has promised to accelerate scientists' understanding of the genetics behind cancer.

Based in Cambridge, U.K., Cytomyx Ltd. is a provider of ion channel cell lines and drug discovery services

AppTec to manufacture multiple sclerosis drug candidate for toxicology studies and clinical trial using ACE System.

Preclinical data for oncogenic B-Raf inhibitor presented at American Association for Cancer Research Annual Meeting.

A unique public-private partnership led by researchers at the Broad Institute of MIT and Harvard creates RNAi-based inhibitors for nearly every human and mouse gene.

Cancer Cell paper validates use of Anti-S1P antibody as a potential therapeutic.